Home
Farallon Capital Partners reported a 8.4% stake in Tango Therapeutics TNGX · 9,157,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 8.4%
- Last report
- 6.6% · filed 25/06/13
- Shares held
- 9,157,000 sh
- Class
- Common stock, par value $0.001 per share (the "Shares")
- Event date
- 25/06/30
- Filed
- 25/08/13
8.4% stake · +1.8pp from the last report
- Stake
- 8.4%
- Last report
- 6.6%
- Since last report
- +1.8pp
Tango Therapeutics trades, last 26 weeks
What else happened in Tango Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Farallon Capital Partners's other 5% stake reports
- Farallon Capital Partners
5% stakeBridgeBio Pharma
5% stakeBridgeBio Pharma
BBIO
5.2% stake
10,226,063 sh
5.2% stake
Filed 05/29
- Farallon Capital Partners
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,500,000 sh
5.1% stake
Filed 05/14
- Farallon Capital Partners
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
6.6% stake
3,580,818 sh
6.6% stake
Filed 05/12
- Farallon Capital Partners
5% stakeBeta Bionics
5% stakeBeta Bionics
BBNX
8.1% stake
3,607,920 sh
8.1% stake
Filed 05/12
- Farallon Capital Partners
5% stakeGrail
5% stakeGrail
GRAL
7.8% stake
3,253,684 sh
7.8% stake
Filed 05/11
